Sign In
Buy AVXL
$2.65
-0.140 (-5.03%)
At Close: Jun 03, 2026
Anavex Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference on February 25, 2021
07:00am, Thursday, 18'th Feb 2021
NEW YORK, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeu
Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q1 2021 Results - Earnings Call Transcript
05:37pm, Friday, 12'th Feb 2021
Anavex Life Sciences Corp. (AVXL) CEO Christopher Missling on Q1 2021 Results - Earnings Call Transcript
Anavex Life Sciences Reports Fiscal 2021 First Quarter Financial Results And Business Outlook
07:00am, Thursday, 11'th Feb 2021
Conference Call and Webcast Today at 4:30 p.m. ET Conference Call and Webcast Today at 4:30 p.m. ET
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook on Thursday, February 11, 2021
07:00am, Monday, 08'th Feb 2021
Conference Call and Webcast To be Held Thursday, February 11, 2021 4:30 pm Eastern Time Conference Call and Webcast To be Held Thursday, February 11, 2021 4:30 pm Eastern Time
AVXL Stock Price Increases Over 60% Pre-Market: Why It Happened
06:23am, Thursday, 04'th Feb 2021
The stock price of Anavex Life Sciences Corp (NASDAQ: AVXL) is trading at over 60% pre-market today as of 6:04 AM ET. This is why it happened.
Biotech Bonanza: COVID Launches Science at Warp Speed
07:41pm, Wednesday, 03'rd Feb 2021
From vaccines to diagnostics, the opportunities in biotechnology are rich for those who do their homework.
Treating The Causes Of Alzheimer's Disease: The Case For Anavex 2-73
12:43am, Friday, 22'nd Jan 2021
Eli Lilly recently released generally positive results for its anti-amyloid drug donanemab. Drugs that directly or indirectly target amyloid oligomers which activate various receptors appear to have l
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference
07:00am, Wednesday, 06'th Jan 2021
NEW YORK, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeu
Anavex Life Sciences (AVXL) Upgraded to Buy: Here's Why
12:48pm, Thursday, 31'st Dec 2020
Anavex Life Sciences (AVXL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Anavex Life Sciences Corp. (AVXL) CEO Dr. Christopher Missling on Q4 2020 Results - Earnings Call Transcript
10:07pm, Monday, 28'th Dec 2020
Anavex Life Sciences Corp. (AVXL) CEO Dr. Christopher Missling on Q4 2020 Results - Earnings Call Transcript
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates
07:00am, Monday, 28'th Dec 2020
Conference Call and Webcast Today at 4:30 p.m. ET Conference Call and Webcast Today at 4:30 p.m. ET
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
07:00am, Tuesday, 22'nd Dec 2020
Conference Call and Webcast To be Held Monday, December 28th, 2020 4:30 pm Eastern Time Conference Call and Webcast To be Held Monday, December 28th, 2020 4:30 pm Eastern Time
NEW YORK, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeu
Why Anavex Life Sciences Stock Jumped Today
05:57pm, Tuesday, 15'th Dec 2020
The company reported positive results from a phase 2 clinical trial.
Primary safety, pharmacokinetics and secondary efficacy endpoints met, with consistent improvements in RSBQ Total scores and CGI-I
